These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 30285213)

  • 21. Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Parikh P; Malhotra H; Jelic S;
    Ann Oncol; 2008 May; 19 Suppl 2():ii27-8. PubMed ID: 18456757
    [No Abstract]   [Full Text] [Related]  

  • 22. Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference.
    Berenguer M; Burra P; Ghobrial M; Hibi T; Metselaar H; Sapisochin G; Bhoori S; Kwan Man N; Mas V; Ohira M; Sangro B; van der Laan LJW
    Transplantation; 2020 Jun; 104(6):1143-1149. PubMed ID: 32217940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment of hepatocellular carcinoma.
    Sugawara Y; Hibi T
    Biosci Trends; 2021 Jul; 15(3):138-141. PubMed ID: 33746184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?
    Ersan V; Barut B; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1152-1156. PubMed ID: 32856230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Jelic S; Sotiropoulos GC;
    Ann Oncol; 2010 May; 21 Suppl 5():v59-64. PubMed ID: 20555104
    [No Abstract]   [Full Text] [Related]  

  • 26. Pediatric Hepatocellular Carcinoma.
    Varol Fİ
    J Gastrointest Cancer; 2020 Dec; 51(4):1169-1175. PubMed ID: 32856229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatocellular carcinoma].
    Semela D; Heim M
    Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are all these HCCs incidental? Think again!
    Altraif I
    Gastroenterology; 1997 Aug; 113(2):730. PubMed ID: 9247499
    [No Abstract]   [Full Text] [Related]  

  • 29. Advances in Hepatocellular Carcinoma.
    Frenette C
    Clin Liver Dis; 2020 Nov; 24(4):xiii-xiv. PubMed ID: 33012459
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Jelic S;
    Ann Oncol; 2009 May; 20 Suppl 4():41-5. PubMed ID: 19454459
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience.
    Victor DW; Monsour HP; Boktour M; Lunsford K; Balogh J; Graviss EA; Nguyen DT; McFadden R; Divatia MK; Heyne K; Ankoma-Sey V; Egwim C; Galati J; Duchini A; Saharia A; Mobley C; Gaber AO; Ghobrial RM
    Transplantation; 2020 Jan; 104(1):113-121. PubMed ID: 31233480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of staging on the treatment of hepatocellular carcinoma.
    Zornig C; Broelsch CE
    Endoscopy; 1993 Jan; 25(1):138-42. PubMed ID: 7681000
    [No Abstract]   [Full Text] [Related]  

  • 33. Malatya and Other Criteria for Liver Transplantation in Hepatocellular Carcinoma.
    Ince V; Ara C; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1118-1121. PubMed ID: 32860615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric hepatocellular carcinoma.
    Khanna R; Verma SK
    World J Gastroenterol; 2018 Sep; 24(35):3980-3999. PubMed ID: 30254403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
    Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of the 8th American Joint Committee on Cancer System for Hepatocellular Carcinoma Staging.
    Satala CB; Jung I; Kobori L; Kovacs Z; Fodor D; Szodorai R; Gurzu S
    J Gastrointest Cancer; 2021 Mar; 52(1):243-248. PubMed ID: 32173767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.
    Loomba R; Lim JK; Patton H; El-Serag HB
    Gastroenterology; 2020 May; 158(6):1822-1830. PubMed ID: 32006545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bridging and downstaging to transplantation in hepatocellular carcinoma.
    Ettorre GM; Levi Sandri GB; Santoro R; Lepiane P; Colasanti M; Vennarecci G
    Future Oncol; 2014 Nov; 10(15 Suppl):61-3. PubMed ID: 25478770
    [No Abstract]   [Full Text] [Related]  

  • 40. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.
    Akateh C; Black SM; Conteh L; Miller ED; Noonan A; Elliott E; Pawlik TM; Tsung A; Cloyd JM
    World J Gastroenterol; 2019 Jul; 25(28):3704-3721. PubMed ID: 31391767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.